Back

Midodrine in treatment of post coronary revascularization vasoplagia; pilot, open label, assessor blinded randomized clinical trial

27 August 2022 (17:15 - 17:45)
Organised by:
Congress Presentation Part of: Treatment of acute heart failure - Pharmacological & non-pharmacological Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Kaveh Hosseini

Herlev and Gentofte Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Meta-analysis comparing the efficacy of dobutamine versus milrinone in acute decompensated heart failure and cardiogenic shock.
Doctor A. Goel (Valhalla, US)
Abstract Slides
Presentation thumbnail
Clinical outcomes of left ventricular unloading with microaxial flow pump Impella during venoarterial extracorporeal membrane oxygenation (VA-ECMO): a systematic review and updated meta-analysis.
Doctor L. Cappannoli (Rome, IT)
Abstract Slides
Presentation thumbnail
Pressure-strain loops unveil hemodynamics behind mechanical circulatory support systems
Doctor G. Mandoli (Siena, IT)
Abstract Slides
Presentation thumbnail
Use of a remote telemonitoring platform significantly improves medication optimisation in heart failure patients
Doctor D. Brahmbhatt (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Treatment of acute heart failure - Pharmacological & non-pharmacological

The Event

Event poster

ESC Congress 2022

27 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources